Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Multiple Sclerosis
Research reports on multiple sclerosis from R.C. Parodi and colleagues provide new insights
May 21st, 2008
"Identification of new enhancing lesions is a major endpoint of longitudinal brain magnetic resonance (MR) studies of multiple sclerosis (MS). To date, this is a visual, time-consuming procedure," scientists in Imperia, Italy report. "We present here a supervised automated procedure (SAP) aimed at reducing the time needed to identify new MS enhancing lesions. The SAP uses an algorithm including Cartesian coordinates of the lesions to be compared, their area and a constant (k). The procedure was validated for enhancing lesions on T1-weighted spin-echo images after intravenous administration of 0.1 mmol/kg, of paramagnetic contrast agent, randomly selected from a dataset...
Source: Immunotherapy Weekly (2008-05-21)
|
